Submitted by Anonymous (not verified) on 1 December 2023 - 13:02
Human medicines European public assessment report (EPAR): Otezla, apremilast, Arthritis, Psoriatic;Psoriasis, Date of authorisation: 15/01/2015, Revision: 21, Status: Authorised
Source: